ENTITY
WuXi AppTec

WuXi AppTec (2359 HK)

347
Analysis
Health CareChina
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
Refresh
bullishWuXi AppTec
06 Dec 2018 17:17

Wuxi Apptec (药明康德) IPO: Pricing Update Before Book Close

Wuxi Apptec (2359 HK)'s USD 1bn IPO is about to close today. As per media report, book runners are guiding a minimum price of HKD 70/share, which...

Logo
609 Views
Share
bearishWuXi AppTec
03 Dec 2018 08:47

Last Week in GER IPO Research: Wuxi, Mobvista, Yancoal, IDreamSky, Mogu, Asiainfo, Softbank & More!

Last week was a busy week for IPO content. In this edition, we highlight a differentiated AH premium piece on pharma outsourcer WuXi AppTec Co....

Logo
399 Views
Share
bullishSoftbank Corp
01 Dec 2018 17:34

ECM Weekly (1 December 2018) - Softbank Corp, Tencent Music, Cansino, Wuxi Apptec, Fosun Tourism

Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...

Share
bearishWuXi AppTec
29 Nov 2018 08:23

WuXi AppTec IPO Valuation: Not Much Money Left on the Table

WuXi AppTec Co. Ltd. (WUXI HK) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....

Logo
592 Views
Share
bullishWuXi AppTec
28 Nov 2018 11:42

WuXi Apptec (药明康德) IPO:Upside at Middle and Low End

Wuxi Apptec launched book building today with a price range of HKD 64.10 to HKD 71.50, planning to raise USD 954 million to USD 1,064 million. In...

Logo
728 Views
Share
x